Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of "gliptins" for treating type 2 diabetes

August 2013

Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of "gliptins" for treating type 2 diabetes.

Nesina is the latest "me too" diabetes drug to hit the market.

Think of it as another Januvia (sitagliptin), Onglyza (saxagliptin), or Tradjenta (linagliptin).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Insurance avoiding billing mishaps to minimize insurance rejections, costly audits, and frustration
Patient Privacy/HIPAA changes in HIPAA privacy and security rules, which need to be implemented by September 23
Insulin V-Go (VEE-go), a new insulin delivery device that's worn like a PATCH
Contraceptives emergency contraceptives (Plan B One-Step, etc) will be available OTC without restrictions
Diabetes Meds Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of "gliptins" for treating type 2 diabetes
Acne younger kids using acne products
Vitamins & Minerals a new version of PreserVision AREDS 2 for age-related macular degeneration (AMD)
Antibiotics LESS use of azithromycin and other "macrolide" antibiotics (clarithromycin, etc) for most acute respiratory infections
Respiratory & Allergy more questions about treating rashes caused by poison ivy, poison oak, or poison sumac
COPD changes in the treatments used for chronic obstructive pulmonary disease (COPD)
Smoking Cessation You might see some Chantix (varenicline) Rxs for both smoking and ALCOHOL abuse and dependence
Storage & Disposal the proper way to store and dispose of meds at home